NextCell Pharma Financials
| NXTCL Stock | SEK 1.75 0.02 1.13% |
NextCell |
Understanding current and past NextCell Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NextCell Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in NextCell Pharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in NextCell Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NextCell Pharma AB. Check NextCell Pharma's Beneish M Score to see the likelihood of NextCell Pharma's management manipulating its earnings.
NextCell Pharma Stock Summary
NextCell Pharma competes with Diamyd Medical, Mendus AB, Vicore Pharma, and Immunovia Publ. NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. NextCell Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009723125 |
| Business Address | Karolinska Institutet Science |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.nextcellpharma.com |
| Phone | 46 87 35 55 95 |
| Currency | SEK - Swedish Kronor |
You should never invest in NextCell Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NextCell Stock, because this is throwing your money away. Analyzing the key information contained in NextCell Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
NextCell Pharma Key Financial Ratios
There are many critical financial ratios that NextCell Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NextCell Pharma AB reports annually and quarterly.NextCell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NextCell Pharma's current stock value. Our valuation model uses many indicators to compare NextCell Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NextCell Pharma competition to find correlations between indicators driving NextCell Pharma's intrinsic value. More Info.NextCell Pharma AB is regarded third in return on equity category among its peers. It also is regarded third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NextCell Pharma's earnings, one of the primary drivers of an investment's value.NextCell Pharma AB Systematic Risk
NextCell Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NextCell Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on NextCell Pharma AB correlated with the market. If Beta is less than 0 NextCell Pharma generally moves in the opposite direction as compared to the market. If NextCell Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NextCell Pharma AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NextCell Pharma is generally in the same direction as the market. If Beta > 1 NextCell Pharma moves generally in the same direction as, but more than the movement of the benchmark.
NextCell Pharma November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NextCell Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NextCell Pharma AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of NextCell Pharma AB based on widely used predictive technical indicators. In general, we focus on analyzing NextCell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NextCell Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.13 | |||
| Information Ratio | 0.1067 | |||
| Maximum Drawdown | 24.29 | |||
| Value At Risk | (4.89) | |||
| Potential Upside | 6.67 |
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.